West Virginia University's Clinical Trials Research Unit (CTRU) is dedicated to providing the services and expertise that investigators need to conduct clinical trials and expand the growing body of biomedical knowledge. We offer a wide range of administrative and budgetary services to both clinical investigators and private industry. Because West Virginia University is the state's primary research institution, the CTRU physicians represent a comprehensive range of specializations. Our staff has a sterling reputation for excellent patient care as well as timely delivery of valid and reliable data. Unlike many other academic health centers, West Virginia University provides primary care services to a large, stable population of rural patients. WVU also provides secondary and tertiary care. Our patient population ensures a high degree of follow-up care and study completion that many other clinical trials facilities cannot offer. Clinical trials are conducted at the West Virginia University Cancer Institute and the Robert C. Byrd Health Sciences Center (HSC) at West Virginia University in Morgantown.
WVCTSI will begin a new four-part Clinical and Translational Research Seminar Series focusing on clinical trials. During the first installment in this new series, Tanya Moran, MS, WVCTSI senior quality assurance and auditing manager, and Shelley Welch, RN, MSHS, CCRC, WVCTSI clinical research services manager, will present “Clinical Trial Data: Good Documentation Practices.”
The WVU Cancer Institute is one of several sites nationwide that participated in a groundbreaking clinical research study of a novel drug proven very effective in the treatment of pediatric and adult cancers that carry a specific genetic mutation.
Congratulations to the WVU Clinical trials Research Unit (CTRU) and Dr. Adham Salkeni, WVU’s principal investigator for the NRG Oncology group, the largest clinical trials collaborative network in the United States. During the recent biannual meeting of the NRG, our CTRU was recognized as among the top ten main member sites to enroll the most patients on cancer clinical trials between January and June 2017. “This places WVU on the national map for clinical trials accrual,” Salkeni said. “This shows that we offer state-of-the-art research studies that examine the role of targeted therapies for the treatment of a wide variety of cancers that affect our patient population.”